Dora Menchaca

1.5k total citations
11 papers, 1.1k citations indexed

About

Dora Menchaca is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Dora Menchaca has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Dora Menchaca's work include Platelet Disorders and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Neutropenia and Cancer Infections (3 papers). Dora Menchaca is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Neutropenia and Cancer Infections (3 papers). Dora Menchaca collaborates with scholars based in United States and Australia. Dora Menchaca's co-authors include Russell L. Basser, C. Glenn Begley, Brian M. Cohen, Dianne Tomita, William Sheridan, John A. Glaspy, Jonathan Cebon, John E.J. Rasko, Richard M. Fox and Kerrie Clarke and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Dora Menchaca

11 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora Menchaca United States 9 816 245 211 194 144 11 1.1k
Satoru Kosugi Japan 18 727 0.9× 115 0.5× 265 1.3× 59 0.3× 133 0.9× 40 1.0k
Josephine Contrino United States 12 415 0.5× 170 0.7× 142 0.7× 195 1.0× 123 0.9× 14 1.0k
H. Pralle Germany 21 1.3k 1.5× 218 0.9× 869 4.1× 284 1.5× 90 0.6× 65 1.8k
Valérie Proulle France 19 606 0.7× 191 0.8× 111 0.5× 45 0.2× 88 0.6× 52 1.0k
R L Nachman United States 8 527 0.6× 134 0.5× 264 1.3× 107 0.6× 80 0.6× 8 866
Brit B. Sørensen Denmark 16 1.1k 1.4× 99 0.4× 423 2.0× 80 0.4× 93 0.6× 29 1.3k
JL Nichol United States 8 724 0.9× 70 0.3× 160 0.8× 51 0.3× 176 1.2× 10 841
Joel Kremer United States 7 534 0.7× 464 1.9× 306 1.5× 214 1.1× 42 0.3× 12 1.5k
Carlos Bueso-Ramos United States 18 1.0k 1.3× 203 0.8× 572 2.7× 208 1.1× 94 0.7× 37 1.7k
L Mangoni Italy 18 504 0.6× 151 0.6× 242 1.1× 220 1.1× 75 0.5× 53 886

Countries citing papers authored by Dora Menchaca

Since Specialization
Citations

This map shows the geographic impact of Dora Menchaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Menchaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Menchaca more than expected).

Fields of papers citing papers by Dora Menchaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Menchaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Menchaca. The network helps show where Dora Menchaca may publish in the future.

Co-authorship network of co-authors of Dora Menchaca

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Menchaca. A scholar is included among the top collaborators of Dora Menchaca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Menchaca. Dora Menchaca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wong, Shekman, David Lau, Sharon A. Baughman, et al.. (2004). Pharmacokinetics and Pharmacodynamics of a Novel Depot Formulation of Abarelix, a Gonadotropin‐Releasing Hormone (GnRH) Antagonist, in Healthy Men Ages 50 to 75. The Journal of Clinical Pharmacology. 44(5). 495–502. 18 indexed citations
2.
Schuster, Michael W., Roy Beveridge, Debra Frei‐Lahr, et al.. (2002). The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation. Experimental Hematology. 30(9). 1044–1050. 24 indexed citations
3.
Basser, Russell L., Elizabeth O’Flaherty, Michael Green, et al.. (2002). Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood. 99(7). 2599–2602. 191 indexed citations
4.
Sheridan, William & Dora Menchaca. (1998). Overview of the safety and biologic effects of peg‐rhumgdf in clinical trials. Stem Cells. 16(S1). 193–198. 1 indexed citations
5.
Basser, R., L.B. To, C. Glenn Begley, et al.. (1998). Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor.. Journal of Clinical Oncology. 16(5). 1899–1908. 27 indexed citations
6.
Fanucchi, Michael, John A. Glaspy, Jeffrey Crawford, et al.. (1997). Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer. New England Journal of Medicine. 336(6). 404–409. 210 indexed citations
7.
8.
Glaspy, John A., Elizabeth J. Shpall, C.F. LeMaistre, et al.. (1997). Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients. Blood. 90(8). 2939–2951. 124 indexed citations
9.
Costa, John J., George D. Demetri, Terence J. Harrist, et al.. (1996). Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.. The Journal of Experimental Medicine. 183(6). 2681–2686. 209 indexed citations
10.
Basser, Russell L., John E.J. Rasko, Kerrie Clarke, et al.. (1996). Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. The Lancet. 348(9037). 1279–1281. 163 indexed citations
11.
Morstyn, George, John A. Glaspy, Elizabeth J. Shpall, et al.. (1994). Clinical Applications of Filgrastim and Stem Cell Factor In Vivo and In Vitro. Journal of Hematotherapy. 3(4). 353–355. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoru Kosugi Breakdown of academic impact, for papers by Josephine Contrino Breakdown of academic impact, for papers by H. Pralle Breakdown of academic impact, for papers by Valérie Proulle Breakdown of academic impact, for papers by R L Nachman Breakdown of academic impact, for papers by Brit B. Sørensen Breakdown of academic impact, for papers by JL Nichol Breakdown of academic impact, for papers by Joel Kremer Breakdown of academic impact, for papers by Carlos Bueso-Ramos Breakdown of academic impact, for papers by L Mangoni
Rankless by CCL
2026